ClinicalTrials.Veeva

Menu

Mail Outreach To Increase Vaccination Acceptance Through Engagement (MOTIVATE)

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Influenza, Human
Influenza
Human Flu

Treatments

Behavioral: Core letter signed by SG + enhanced implementation prompt
Behavioral: Core letter signed by the Director of the National Vaccine Program
Behavioral: Core letter signed by Surgeon General
Behavioral: Core letter signed by Surgeon General + implementation prompt

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT02243774
2014-P-001821

Details and patient eligibility

About

The aim of this study is to determine whether receiving a core letter signed by the Surgeon General or the Director of the National Vaccine Program that provides only information about influenza, or a core letter signed by the Surgeon General with an added basic or enhanced implementation prompt, will increase rates of influenza vaccination among Medicare beneficiaries when compared to a control group.

Enrollment

228,000 patients

Sex

All

Ages

66+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Medicare fee-for-service beneficiaries aged 66 and older are eligible for study inclusion. There will be no additional exclusion criteria.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

228,000 participants in 5 patient groups

No letter
No Intervention group
Description:
Individuals randomized to the control group who will not receive any of the four letters
Core letter signed by Surgeon General
Experimental group
Description:
Individuals randomized to receive only a core letter signed by the Surgeon General
Treatment:
Behavioral: Core letter signed by Surgeon General
Core letter signed by Director of the National Vaccine Program
Experimental group
Description:
Individuals randomized to receive only a core letter signed by the Director of the National Vaccine Program
Treatment:
Behavioral: Core letter signed by the Director of the National Vaccine Program
Core letter signed by Surgeon General + implementation prompt
Experimental group
Description:
Individuals randomized to receive a core letter signed by the Surgeon General with an implementation intention prompt added in an appended P.S. tag region below the signature line
Treatment:
Behavioral: Core letter signed by Surgeon General + implementation prompt
Core letter signed by SG + enhanced implementation prompt
Experimental group
Description:
Individuals randomized to receive a core letter signed by the Surgeon General (SG) with an enhanced implementation intention prompt added in an appended P.S. tag region below the signature line
Treatment:
Behavioral: Core letter signed by SG + enhanced implementation prompt

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems